Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TFRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MLLT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REXO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCARF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA2P3Y - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC400541 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASL10B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSC5D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UNC93B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBPL11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PODXL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPT-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on